Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for Smoking Cessation
NCT02044874Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorcaserin in nicotine dependence, sponsored by Arena Pharmaceuticals, Inc.. Started Mar 2014; status: completed.
02
Drugs
lorcaserin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02044874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02044874.